SEC Form 4 · accession 0001070081-19-000009

PTC THERAPEUTICS, INC. · PTCT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Stuart Walter Peltz

Officer — Chief Executive Officer · Director

Period of report

Jan 7, 2019

Accepted (ET)

Jan 9, 2019 · 5:09 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070081

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jan 7, 2019	S	1,764	$34.75	D	24,882	D
Common Stock^F2,F3,F4	Jan 7, 2019	S	339	$34.75	D	17,947	I	By Spouse
Common Stock^F5,F4	Jan 7, 2019	S	409	$34.75	D	17,538	I	By Spouse

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right To Buy)^F4,F6	$451.20	holding	—	—	—	—	May 15, 2019	Common Stock	41	41	I
Stock Option (Right To Buy)^F4,F6	$1,149.60	holding	—	—	—	—	Feb 2, 2020	Common Stock	37	37	I
Stock Option (Right To Buy)^F4,F6	$490.80	holding	—	—	—	—	Apr 27, 2021	Common Stock	58	58	I
Stock Option (Right To Buy)^F4,F6	$218.40	holding	—	—	—	—	Jan 10, 2022	Common Stock	38	38	I
Stock Option (Right To Buy)^F4,F6	$10.85	holding	—	—	—	—	May 15, 2023	Common Stock	3,900	3,900	I
Stock Option (Right To Buy)^F4,F6	$27.05	holding	—	—	—	—	Jan 28, 2024	Common Stock	4,900	4,900	I
Stock Option (Right To Buy)^F4,F6	$51.00	holding	—	—	—	—	Jan 2, 2025	Common Stock	10,880	10,880	I
Stock Option (Right To Buy)^F4,F7	$30.86	holding	—	—	—	—	Jan 3, 2026	Common Stock	11,000	11,000	I
Stock Option (Right To Buy)^F4,F8	$12.64	holding	—	—	—	—	Nov 16, 2026	Common Stock	2,000	2,000	I
Stock Option (Right To Buy)^F4,F9	$11.23	holding	—	—	—	—	Jan 2, 2027	Common Stock	12,600	12,600	I
Stock Option (Right To Buy)^F4,F10	$18.01	holding	—	—	—	—	Jan 2, 2028	Common Stock	30,625	30,625	I

Explanation of responses

F1Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock.
F10This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
F2Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.
F3Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019.
F4The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018.
F5Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
F6Currently exercisable.
F7This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F8This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
F9This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.